In these politically divided times, it’s hard to imagine how people of very different perspectives can still be friends, but ...

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with ...

ACESOT-1051 trial evaluating WEE1 kinase inhibitor APR-1051 now enrolling patients in Cohort 5; open label safety and efficacy data expected H2 ...

Jack never had the 21st birthday party he had been planning in our garden. Instead of birthday cards for him we received ...

Timbercreek Financial (the "Company") is pleased to announce that it has declared a monthly cash dividend of $0.0575 per common share ("Common Share") of the Company to be paid on April 15, 2025 to ...

Global X Investments Canada Inc. ("Global X") is pleased to announce the distribution amounts per security (the "Distributions") for its exchange traded funds (the "ETFs"), for the period ending March ...